How might Thirty Madison expand its Evens acid reflux treatment offerings to better serve patients with different severity levels?

Introduction

To address Thirty Madison's expansion of Evens acid reflux treatment offerings, we need to consider how to better serve patients with different severity levels. This involves understanding the current product landscape, user segments, pain points, and potential solutions. I'll approach this challenge systematically, focusing on user needs and product improvements that align with Thirty Madison's goals.

Step 1

Clarifying Questions (5 mins)

• Looking at Evens' current offerings, I'm curious about the range of severity levels we're currently addressing. Could you provide more insight into the types of acid reflux cases Evens currently treats, from mild to severe?

Why it matters: This helps us identify gaps in our current offerings and potential areas for expansion. Expected answer: Evens primarily focuses on mild to moderate cases. Impact on approach: If confirmed, we'd focus on expanding into more severe cases or specialized treatments.

• Considering the telehealth nature of Evens, I'm wondering about our current patient engagement model. How do we currently monitor patient progress and adjust treatments over time?

Why it matters: Understanding our current follow-up process helps identify opportunities for improvement in long-term care. Expected answer: Limited follow-up, mostly patient-initiated. Impact on approach: We might focus on developing a more proactive, data-driven follow-up system.

• Given the competitive landscape in digital health, I'm interested in our key differentiators. What unique features or approaches set Evens apart from traditional acid reflux treatments or other telehealth competitors?

Why it matters: Helps us build on our strengths and address weaknesses in our expansion strategy. Expected answer: Convenience of telehealth, personalized treatment plans. Impact on approach: We could focus on enhancing personalization or expanding our convenience features.

• Considering Thirty Madison's broader portfolio, I'm curious about potential synergies. Are there opportunities to leverage data or technologies from other Thirty Madison brands to enhance Evens' offerings?

Why it matters: Identifies potential cross-brand opportunities for innovation and efficiency. Expected answer: Some shared backend systems, but limited cross-brand data utilization. Impact on approach: We might explore ways to integrate insights from other brands to enhance Evens' treatment options.